Dr. Christine Landlinger-Schubert
October 25, 2019

Lorenzo has long been fascinated by the many examples of phages effectively treating bacterial infections. And by how under-exploited this extremely abundant natural resource is. Lorenzo spent the last 9 years at the Boston Consulting Group (BCG) and was a Senior Principal in his latest role.
Lorenzo has advised the top Biopharmaceutical companies, on how to improve their quality and efficiency of production. Earlier in his career he worked at Sanofi Aventis in lead optimization after high-throughput screening. Lorenzo co-founded PhagoMed in 2017 and currently serves as CEO with a focus on the Research & Development responsibilities. Lorenzo studied biochemistry at Frankfurt University and holds a PhD from the European Molecular Biology Laboratory (EMBL) in Heidelberg.